What Medicare Claims Reveal About Adverse Drug Events
April 18, 2019
Resources for Payers, Patients, Caregivers, Providers, Pharmacists, and Researchers
Recognized as a largely preventable source of harm to patients, Adverse Drug Events (ADEs) are a public health issue that require ongoing surveillance. Seniors are especially vulnerable with more than 40 percent taking five or more medications to manage chronic conditions such as hypertension, diabetes, COPD, and heart failure.
Despite the known risk, there is no national system for measuring and monitoring outpatient ADE rates among seniors. A team of Telligen data analysts, working under contract with CMS, addressed this limitation by developing a method that uses Medicare claims to:
- Identify populations at high-risk for adverse events;
- Calculate rates of hospitalization among the high-risk population; and
- Share the data for targeted quality interventions.
The end result is a population health monitoring source for tracking medication use patterns, health outcomes, and ADE rates for targeted quality improvement efforts.
Telligen ADE Resources:
What payers, patients, providers, and pharmacists need to know about ADEs among elderly populations
Overview of the objectives, methods, and results of Telligen’s peer-reviewed study
Published in the March 2019 issue of Journal of Managed Care & Specialty Pharmacy
How the study will can help Medicare enhance prevention and monitoring for quality improvement efforts